Our study confirmed a significant overexpression of osteopontin and CHI3L1 in the CSF and serum of DIPG patients, but whether these proteins could be used as biomarkers for DIPG progression needs to be assessed in prospective work. Here, CHI3L1 is linked to diffuse intrinsic pontine glioma.